Form 4 for ALT Altimmune, Inc.

Accepted 2022-06-28 00:00:00 ET · period of report 2022-06-27 · accession 0001104659-22-075223 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-06-28	2022-06-27	ALT	Jorkasky Diane	Dir	M - OptEx	$3.15	+17.6K	17.6K	New	+$55.5K
D	2022-06-28	2022-06-27	ALT	Jorkasky Diane	Dir	S - Sale+OE	$11.75	-17.6K	0	-100%	-$206.9K
D	2022-06-28	2022-06-27	ALT	Jorkasky Diane	Dir	M - OptEx	$0.00	-17.6K	22.4K	-44%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, par value $0.0001	2022-06-27	M	A	17,610	$3.15	17,610	D	—	—
2	Common	Common Stock, par value $0.0001	2022-06-27	S	D	17,610	$11.75	0	D	—	—	(F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.75 to $11.88, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3	Derivative	Stock Options (option to buy)	2022-06-27	M	D	17,610	$0.00	22,390	D	$3.15 · — to 2030-05-11	40,000 Common Stock, par value $0.0001	(F3) The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments, subject to the reporting person's continued service through the applicable vesting date.